PEJM.F logo

Peijia Medical OTCPK:PEJM.F Stock Report

Last Price

US$1.39

Market Cap

US$887.8m

7D

0%

1Y

n/a

Updated

12 Apr, 2023

Data

Company Financials +

Peijia Medical Limited

OTCPK:PEJM.F Stock Report

Market Cap: US$887.8m

PEJM.F Stock Overview

Engages in the research and development of transcatheter valve therapeutic and neuro interventional procedural medical devices. More details

PEJM.F fundamental analysis
Snowflake Score
Valuation2/6
Future Growth5/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Peijia Medical Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Peijia Medical
Historical stock prices
Current Share PriceHK$1.39
52 Week HighHK$1.39
52 Week LowHK$1.39
Beta0.24
11 Month Change0%
3 Month Changen/a
1 Year Changen/a
33 Year Changen/a
5 Year Changen/a
Change since IPO0%

Recent News & Updates

Recent updates

Shareholder Returns

PEJM.FUS Medical EquipmentUS Market
7D0%1.5%2.2%
1Yn/a20.8%31.6%

Return vs Industry: Insufficient data to determine how PEJM.F performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how PEJM.F performed against the US Market.

Price Volatility

Is PEJM.F's price volatile compared to industry and market?
PEJM.F volatility
PEJM.F Average Weekly Movementn/a
Medical Equipment Industry Average Movement8.1%
Market Average Movement6.3%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market3.1%

Stable Share Price: PEJM.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine PEJM.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2012927Yi Zhangwww.peijiamedical.com

Peijia Medical Limited engages in the research and development of transcatheter valve therapeutic and neuro interventional procedural medical devices. Its transcatheter valve therapeutic products include TaurusOne, a transcatheter aortic valve replacement (TAVR) system; TaurusElite, a retrievable TAVR system; TaurusNXT, a non-glutaraldehyde crosslinking dry-tissue TAVR system; TaurusWave, a lithotripsy valvuloplasty system; TaurusApex, a polymer leaflets TAVR system; Trilogy, a TAVR System; HighLife, a transseptal mitral value replacement system; SpyderOne, a transapical transcatheter mitral valve replacement (TMVR) system; Sutra, a TMV coaptation augmentation system; GeminiOne, a transcatheter edge-to-edge repair system; MonarQ and Peijia, which are transcatheter tricuspid valve replacement systems; TaurusAtlas, a transfemoral ballon catheter; TaurusExplora, a pre-shaped guidewire; and introducer sheath. The company also offers Jasper and Presgo, that are detachable coils; Jasper SS detachable coil; intracranial adjunctive stents; SacSpeed, a balloon dilatation catheter; Tethys AS, an aspiration catheter; Syphonet, a stent retriever; Neway, a balloon microcatheter; Fluxcap, a balloon guiding catheter; NeuroStellar, an intracranial stent; Presgo microcatheter and micro guidewire; Heralder guiding catheter and distal access catheter; Tethys, an intermediate catheter; and Jasper power supply.

Peijia Medical Limited Fundamentals Summary

How do Peijia Medical's earnings and revenue compare to its market cap?
PEJM.F fundamental statistics
Market capUS$887.76m
Earnings (TTM)-US$59.21m
Revenue (TTM)US$36.42m

24.5x

P/S Ratio

-15.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PEJM.F income statement (TTM)
RevenueCN¥250.83m
Cost of RevenueCN¥74.63m
Gross ProfitCN¥176.20m
Other ExpensesCN¥584.01m
Earnings-CN¥407.81m

Last Reported Earnings

Dec 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.61
Gross Margin70.25%
Net Profit Margin-162.58%
Debt/Equity Ratio4.8%

How did PEJM.F perform over the long term?

See historical performance and comparison